Viking Holdings heads into its Q1 earnings print — due May 14 — with a notable divergence: short interest has been quietly building while options traders have turned their most bullish in months.
The options story is the standout this week. The put/call ratio dropped sharply to 1.25 on May 12, more than two standard deviations below its 20-day average of 1.75 — the most call-heavy reading in the last several months. This is a striking reversal. For much of April, the PCR ran between 1.9 and 2.0, suggesting heavy downside protection. That protection is being unwound almost entirely as the earnings date approaches. Whether that reflects genuine conviction or simply the decay of expiring puts is worth watching closely.
Short interest tells a less comfortable story. Bears have been adding. SI climbed 37% over the past month to reach 2.6% of the free float — still a modest absolute level, but the pace of the build is notable. From roughly 5.6 million shares short in early April, the position grew to just over 8.1 million by May 12. Borrow cost has also moved, more than doubling over the same period to around 0.50%, though that remains well below any squeeze threshold. Availability remains loose: with utilization well under 2%, far below its 52-week peak of 5.5%, the borrow market is not even approaching stress.
The Street is firmly in the bulls' corner ahead of the print. Eleven analysts carry buy-equivalent ratings, with no sells on the register. Morgan Stanley raised its target to $81 on May 12, maintaining Overweight. JP Morgan had already moved more aggressively in late April, lifting its target from $87 to $104 while staying Overweight. Susquehanna initiated fresh coverage with a $100 target, and Rothschild upgraded to Buy with a $95 target. The consensus message: capacity growth should drive a meaningful EBITDA step-up in 2026 and 2027, and booking trends heading into summer look healthy. The pushback comes from valuation — Wells Fargo and Barclays both hold Equal-Weight ratings near the current price, and the bears flag execution risk around capacity ramp, potential yield deterioration, and macro exposure. The EV/EBITDA multiple has compressed modestly over 30 days to around 16.6x, but the stock trades at a price-to-book of 11.6x, which leaves little margin for disappointment.
The insider picture is one-directional, though not alarming. EVP Jeffrey Dash sold roughly $7.9 million of stock across three transactions in March and April, at prices ranging from $75 to $80. The sales are spread over several weeks rather than concentrated — more consistent with pre-planned selling than a sudden change in view — but the pattern is worth noting given the stock has barely moved since those disposals.
The prior earnings reaction, on March 11, was a 1-day drop of 6.2% followed by near-flat performance over the subsequent week. The print before that (March 3) saw a 1.7% gain on day one but a 2.4% drift lower by day five. Neither reaction was catastrophic, but neither established a pattern of post-earnings strength. Close cruise peers CCL, RCL, and NCLH all fell between 2% and 5.5% on the week, underperforming VIK's more contained 1.4% slide — suggesting the sector broadly faces headwinds rather than anything company-specific.
What to watch: whether the Q1 print substantiates the capacity-led EBITDA narrative that has driven the wave of analyst target increases, and whether the abrupt reversal in options positioning reflects investors removing hedges with genuine confidence or simply a mechanical reshuffling ahead of expiry.
See the live data behind this article on ORTEX.
Open VIK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
